Quick Answer
Pulmatrix, Inc. reported Cash and Equivalents of $4.09 million for fiscal year 2025.
Pulmatrix, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $4.09M | -57.1% |
| 2024 | $9.52M | -50.3% |
| 2023 | $19.17M | -46.2% |
| 2022 | $35.63M | -33.8% |
| 2021 | $53.84M | +70.1% |
| 2020 | $31.66M | +35.1% |
| 2019 | $23.44M | +814.6% |
| 2018 | $2.56M | -27.8% |
| 2017 | $3.55M | -15.1% |
| 2016 | $4.18M | -77.9% |
| 2015 | $18.90M | +4091.1% |
| 2014 | $451.0K | -68.4% |
| 2013 | $1.43M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.79M | -55.5% | -17.7% |
| June 30, 2025 | $5.83M | -52.9% | -24.4% |
| March 31, 2025 | $7.71M | -52.7% | -19.0% |
| December 31, 2024 | $9.52M | -50.3% | -11.7% |
| September 30, 2024 | $10.78M | -49.5% | -12.9% |
| June 30, 2024 | $12.38M | -52.0% | -24.1% |
| March 31, 2024 | $16.30M | -47.0% | -15.0% |
| December 31, 2023 | $19.17M | -46.2% | -10.1% |
- Pulmatrix, Inc. showed a decrease of -57.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2013–2025 period, Pulmatrix, Inc.’s cash and equivalents has grown by 186.9% (from $1.43 million to $4.09 million).
- The most recent figure is from Pulmatrix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: